DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

Translate to Spanish or other 102 languages!

Dr. R. Alejandro Cruz, DHR Health Neurologist. Photo Courtesy DHR Health
- Advertisement -

Edinburg, Texas: DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

Under the expert guidance of neurologist Dr. R. Alejandro Cruz and the dedicated team at the DHR Health Neuroscience Institute, comprehensive protocols have been meticulously developed for administering Leqembi. These protocols encompass every aspect of patient care, from initial assessments to laboratory testing, radiology procedures, and establishing a state-of-the-art infusion center.

“I am very proud of the hard work of our team at DHR Health. Being the first facility to provide this groundbreaking therapy for Alzheimer’s disease marks a new era of hope for our community,” said Dr. R. Alejandro Cruz, DHR Health Neurologist.

- Advertisement -

As the largest physician-owned hospital in the United States and a leading healthcare provider in the Rio Grande Valley, DHR Health is immensely proud to be at the forefront of Alzheimer’s disease treatment in South Texas. “This achievement represents our ongoing commitment to bringing innovative and advanced treatment options to our community. We are proud to provide world-class care close to home,” said Marissa Castañeda, Senior Executive Vice President at DHR Health.

Dr. Cruz explains that Alzheimer’s disease is a progressive brain disorder characterized by changes in the brain that lead to the accumulation of certain proteins. These changes cause the brain to shrink and brain cells to die, resulting in dementia, which manifests as a gradual decline in memory, thinking, behavior, and social skills. The introduction of Leqembi offers hope for those affected by this debilitating condition, with the potential to improve quality of life and slow disease progression.

DHR Health continues delivering exceptional care, announcing a new chapter in Alzheimer’s treatment for the Rio Grande Valley. If you or a loved one are affected by Alzheimer’s, we encourage you to take the next step. To learn more about this groundbreaking treatment or to make an appointment, please contact the DHR Health Neuroscience Institute at (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

$5.5 Million in Grants Awarded to Expand Texas Healthcare Services

Three Statewide Preceptorship Program (SPP) grants were awarded totaling $5.5 million to professional medical societies in Texas. The grants support hands-on training for Texas medical students in family medicine, general internal medicine, and pediatrics, including pediatric subspecialties. 

STHS Shares Essential Summer Food Safety Tips

Because most foodborne illnesses are preventable, proper food safety practices are key to keeping every summer meal safe.

DHR Health Transplant Institute Earns Top State and National Rankings

The DHR Health Transplant Institute announced today that it has been recognized among the state’s and nation’s top performing kidney transplant centers, earning the no. 2 ranking in the State and no. 16 ranking in the Nation, according to the Scientific Registry of Transplant Recipients (SRTR).  

STHS McAllen Receives National Award for Advancing Cardiac Arrest Care & Improving Patient Survival

In the moments following cardiac arrest, every second counts. Rapid intervention, seamless teamwork and evidence-based care can make the difference between life and death.
- Advertisement -